A Population-level Analysis of the Differing Effects of Rheumatoid Arthritis and Spondyloarthritis on Peripartum Outcomes

REFERENCES

1. 1.↵
   1. Tobon GJ,
   2. Youinou P,
   3. Saraux A

   . The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010;A288–92.
2. 2.↵
   1. Stolwijk C,
   2. Van Onna M,
   3. Boonen A,
   4. Van Tubergen A

   . Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arth Care Res 2016;68:1320–1331.

   OpenUrl
3. 3.↵
   1. Bakland G,
   2. Nossent HC

   . Epidemiology of spondyloarthritis: a review. Curr Rheumatol Rep 2013;15:1.

   OpenUrl
4. 4.↵
   1. Dean LE,
   2. Jones GT,
   3. MacDonald AG,
   4. Downham C,
   5. Sturrock RD,
   6. Macfarlane GJ

   . Global prevalence of ankylosing spondylitis. Rheumatology 2014;53:650–7.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Gibofsky A

   . Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care 2014;20:128.

   OpenUrl
6. 6.↵
   1. Ronneberger M,
   2. Schett G

   . Pathophysiology of spondyloarthritis. Curr Rheumatol Rep 2011;13:416–20.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Veale DJ

   . Psoriatic arthritis: recent progress in pathophysiology and drug development. Arthritis Res Ther 2013;15:224.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Wallenius M,
   2. Salvesen KA,
   3. Daltveit AK,
   4. Skomsvoll JF

   . Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry. Acta Obstet Gynecol Scand 2014;93:302–7.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Langen ES,
   2. Chakravarty EF,
   3. Liaquat M,
   4. El-Sayed YY,
   5. Druzin ML

   . High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 2014;31:9–14.

   OpenUrlPubMed
10. 10.↵
    1. Mecacci F,
    2. Pieralli A,
    3. Bianchi B,
    4. Paidas MJ

    . The impact of autoimmune disorders and adverse pregnancy outcome. Semin Perinatol 2007;31:223–6.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Chakravarty EF,
    2. Nelson L,
    3. Krishnan E

    . Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:899–907.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Jakobsson GL,
    2. Stephansson O,
    3. Askling J,
    4. Jacobsson LT

    . Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study. Ann Rheum Dis 2016;75:1838–42.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Timur H,
    2. Tokmak A,
    3. Turkmen GG,
    4. Ali Inal H,
    5. Uygur D,
    6. Danisman N

    . Pregnancy outcome in patients with ankylosing spondylitis. J Matern Fetal Neonatal Med 2016;29:2470–4.

    OpenUrl
14. 14.↵
    1. Zhou Q,
    2. Bian XM,
    3. Liu JT

    . Management of pregnancy with ankylosing spondylitis. Chin Med Sci J 2012;27:46–9.

    OpenUrlPubMed
15. 15.↵
    1. Mouyis MA,
    2. Thornton CC,
    3. Williams D,
    4. Giles IP

    . Pregnancy outcomes in patients with psoriatic arthritis. J Rheumatol 2017;44:128–9.

    OpenUrlFREE Full Text
16. 16.↵
    1. Yang YW,
    2. Chen CS,
    3. Chen YH,
    4. Lin HC

    . Psoriasis and pregnancy outcomes: a nationwide population-based study. J Am Acad Dermatol 2011;64:71–7.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Cohen-Barak E,
    2. Nachum Z,
    3. Rozenman D,
    4. Ziv M

    . Pregnancy outcomes in women with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol 2011;25:1041–7.

    OpenUrlPubMed
18. 18.↵
    1. Lima XT,
    2. Janakiraman V,
    3. Hughes MD,
    4. Kimball AB

    . The impact of psoriasis on pregnancy outcomes. J Invest Dermatol 2012;132:85–91.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Koren G,
    2. Florescu A,
    3. Costei AM,
    4. Boskovic R,
    5. Moretti ME

    . Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006;40:824–9.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Daniel S,
    2. Koren G,
    3. Lunenfeld E,
    4. Bilenko N,
    5. Ratzon R,
    6. Levy A

    . Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions. CMAJ 2014;186:177.

    OpenUrlFREE Full Text
21. 21.↵
    1. Ostensen M,
    2. Khamashta M,
    3. Lockshin M,
    4. Parke A,
    5. Brucato A,
    6. Carp H,
    7. et al.

    Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Makol A,
    2. Wright K,
    3. Amin S

    . Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management. Drugs 2011;71:1973–87.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Hyrich KL,
    2. Verstappen SM

    . Biologic therapies and pregnancy: the story so far. Rheumatology 2014;53:1377–85.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Petri M

    . Immunosuppressive drug use in pregnancy. Autoimmunity 2003;36:51–6.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Bowker SL,
    2. Savu A,
    3. Yeung RO,
    4. Johnson JA,
    5. Ryan EA,
    6. Kaul P

    . Patterns of glucose-lowering therapies and neonatal outcomes in the treatment of gestational diabetes in Canada, 2009–2014. Diabet Med 2017;34:1296–302.

    OpenUrl
26. 26.↵
    1. World Population Review

    . Alberta population 2019. [Internet. Accessed July 18, 2019.] Available from: www.worldpopulationreview.com/canadian-provinces/alberta-population/
27. 27.↵
    1. Bailu R,
    2. Chiu M,
    3. Amin S,
    4. Ramani M,
    5. Sadry S,
    6. Tu J

    . Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med Res Method 2010;10:42.

    OpenUrl
28. 28.↵
    1. Quan H,
    2. Wang F,
    3. Schopflocher D,
    4. Norris C,
    5. Galbraith P,
    6. Faris,
    7. et al.

    Development and validation of a surname list to define Chinese ethnicity. Medical Care 2006;44:328–33.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Yeung R,
    2. Savu A,
    3. Kinniburgh B,
    4. Lee L,
    5. Dzakpasu S,
    6. Nelson C,
    7. et al.

    Prevalence of gestational diabetes among Chinese and South Asians: A Canadian population-based analysis. J Diabetes Complications 2017;31:529–36.

    OpenUrl
30. 30.↵
    1. Widdifield J,
    2. Labrecque J,
    3. Lix L,
    4. Paterson JM,
    5. Bernatsky S,
    6. Tu K,
    7. et al.

    Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases. Arthritis Care Res 2013;65:1490–503.

    OpenUrl
31. 31.↵
    1. Bernatsky S,
    2. Linehan T,
    3. Hanly JG

    . The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 2011;38:1612–16.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Singh JR,
    2. Holmgren AR,
    3. Krug H,
    4. Noorbaloochi S

    . Accuracy of the diagnoses of spondyloarthritides in Veterans Affairs medical center databases. Arthritis Care Res 2007;57:648–55.

    OpenUrl
33. 33.↵
    1. Bowker SL,
    2. Savu A,
    3. Donovan LE,
    4. Johnson JA,
    5. Kaul P

    . Validation of administrative and clinical case definitions for gestational diabetes mellitus against laboratory results. Diabet Med 2017;34:781–5.

    OpenUrl
34. 34.↵
    1. Allen VM,
    2. Dodds L,
    3. Spencer A,
    4. Cummings EA,
    5. MacDonald N,
    6. Kephart G

    . Application of a national administrative case definition for the identification of pre-existing diabetes mellitus in pregnancy. Chronic Dis Inj Can 2012;32:113–20.

    OpenUrlPubMed
35. 35.↵
    1. Kramer MS,
    2. Platt RW,
    3. Wen W,
    4. Joseph KS,
    5. Allen A,
    6. Abrahamowicz M,
    7. et al.

    A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Twilley L,
    2. Wang FL

    . Predictors of preterm and small for gestational age births in Alberta. Edmonton: Alberta Health and Wellness; 2006.
37. 37.↵
    1. Nagara S,
    2. Barnabe C,
    3. Schieir O,
    4. Pope J,
    5. Bartlett SJ,
    6. Boire G,
    7. et al.

    Early rheumatoid arthritis presentation, treatment, and outcomes in aboriginal patients in Canada: a Canadian early arthritis cohort study analysis. Arthritis Care Res 2018;70:1245–50.

    OpenUrl
38. 38.↵
    1. Ursini F,
    2. Russo E,
    3. D’Angelo S,
    4. Arturi F,
    5. Hribal ML,
    6. D’Antona L,
    7. et al.

    Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT study. Medicine 2016;95:e2552.

    OpenUrl
39. 39.↵
    1. Tentolouris N,
    2. Arapostathi C,
    3. Voulgari C,
    4. Grammatikou S,
    5. Andrianakos A,
    6. Sfikakis PP

    . The effect of diabetes mellitus on the prevalence of rheumatoid arthritis: a case-control study. Diabet Med 2008;25:1010–1.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Ruscitti P,
    2. Ursini F,
    3. Cipriani P,
    4. Ciccia F,
    5. Liakouli V,
    6. Carubbi F,
    7. et al.

    Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: results from a cross-sectional study. Medicine 2017;96:e7896.

    OpenUrl
41. 41.↵
    1. Panoulas VF,
    2. Douglas KM,
    3. Milionis HJ,
    4. Stavropoulos-Kalinglou A,
    5. Nightingale P,
    6. Kita MD,
    7. et al.

    Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology 2007;46:1477–82.

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Tokoroyama T,
    2. Ando M,
    3. Setoguchi K,
    4. Tsuchiya K,
    5. Nitta K

    . Prevalence, incidence and prognosis of chronic kidney disease classified according to current guidelines: a large retrospective cohort study of rheumatoid arthritis patients. Nephrol Dial Transplant 2017;32:2035–42.

    OpenUrl
43. 43.↵
    1. Wolfe F,
    2. Freundlich B,
    3. Straus WL

    . Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003;30:36–40.

    OpenUrlAbstract/FREE Full Text
44. 44.↵
    1. Joshi P,
    2. Agarwal A,
    3. Vyas S,
    4. Kumar R

    . Prevalence of hypothyroidism in rheumatoid arthritis and its correlation with disease activity. Trop Doct 2017;47:6–10.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Bobotsis R,
    2. Gulliver WP,
    3. Monaghan K,
    4. Lynde C,
    5. Fleming P

    . Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies. Br J Dermatol 2016;175:464–72.

    OpenUrl
46. 46.↵
    1. Broms G,
    2. Haerskjold A,
    3. Granath F,
    4. Kieler H,
    5. Pedersen L,
    6. Berglind A

    . Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden. Acta Derm Venereol 2018;98:728–34.

    OpenUrl
47. 47.↵
    1. Brodell RT,
    2. Williams L

    . A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. Postgrad Med 1999;106:31–2.

    OpenUrlPubMed
48. 48.↵
    1. Abel EA,
    2. DiCicco LM,
    3. Orenberg EK,
    4. Fraki JE,
    5. Farber EM

    . Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007–22.

    OpenUrlCrossRefPubMed
49. 49.↵
    1. Gerosa M,
    2. Schioppo T,
    3. Meroni PL

    . Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert Opin Pharmacother 2016;17:1539–47.

    OpenUrl
50. 50.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Landewe R,
    4. Akkoc N,
    5. Brandt J,
    6. Chou CT,
    7. et al.

    The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25–31.

    OpenUrlAbstract/FREE Full Text